Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component 5A receptor 2 (C5AR2/C5L2/GPR77) is an atypical member of the anaphylatoxin receptor family involved in fine-tuning inflammatory processes through complex regulatory mechanisms beyond simple ligand sequestration. It represents both a challenge and opportunity for immunology research due to its nuanced roles across health and disease states.
Modulation of C5a-mediated signaling, β-arrestin recruitment, ERK signaling modulation, regulation of NLRP3 inflammasome activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Component 5a Receptor 2 (C5aR2).